Alterity Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Other Revenue	5.44	4.02	3.92	5.12	4.34	Upgrade
Revenue	5.44	4.02	3.92	5.12	4.34	Upgrade
Revenue Growth (YoY)	35.32%	2.63%	-23.56%	18.06%	-	Upgrade
Cost of Revenue	0.13	0.21	0.29	0.36	0.36	Upgrade
Gross Profit	5.31	3.8	3.63	4.76	3.98	Upgrade
Selling, General & Admin	5.48	4.76	5.06	5.51	6.94	Upgrade
Research & Development	14.4	18.64	13.2	14.75	12.28	Upgrade
Other Operating Expenses	0.09	0.01	0.03	0	0	Upgrade
Operating Expenses	19.97	23.41	18.27	20.26	19.16	Upgrade
Operating Income	-14.66	-19.61	-14.64	-15.5	-15.18	Upgrade
Interest & Investment Income	0.45	0.27	0.02	0	0.02	Upgrade
Currency Exchange Gain (Loss)	0.26	0.26	0.92	2.72	-0.3	Upgrade
Other Non Operating Income (Expenses)	-0.33	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-14.28	-19.08	-13.7	-12.78	-15.45	Upgrade
Other Unusual Items	1.98	-	-	-	0.15	Upgrade
Pretax Income	-12.08	-19.08	-13.7	-12.78	-15.31	Upgrade
Income Tax Expense	0.07	0.05	0.1	0.07	-	Upgrade
Net Income	-12.15	-19.12	-13.81	-12.85	-15.31	Upgrade
Net Income to Common	-12.15	-19.12	-13.81	-12.85	-15.31	Upgrade
Shares Outstanding (Basic)	6,397	3,649	2,428	2,406	1,697	Upgrade
Shares Outstanding (Diluted)	6,397	3,649	2,428	2,406	1,697	Upgrade
Shares Change (YoY)	75.31%	50.29%	0.91%	41.79%	89.62%	Upgrade
EPS (Basic)	-0.00	-0.01	-0.01	-0.01	-0.01	Upgrade
EPS (Diluted)	-0.00	-0.01	-0.01	-0.01	-0.01	Upgrade
Free Cash Flow	-11.45	-12.61	-20.04	-12.43	-17.34	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.01	-0.01	Upgrade
Gross Margin	97.66%	94.67%	92.72%	92.88%	91.70%	Upgrade
Operating Margin	-269.57%	-487.82%	-373.72%	-302.56%	-349.77%	Upgrade
Profit Margin	-223.35%	-475.79%	-352.54%	-250.75%	-352.78%	Upgrade
Free Cash Flow Margin	-210.54%	-313.78%	-511.78%	-242.54%	-399.59%	Upgrade
EBITDA	-14.63	-19.57	-14.6	-15.48	-15.16	Upgrade
EBITDA Margin	-269.05%	-	-	-	-	Upgrade
D&A For EBITDA	0.03	0.04	0.04	0.02	0.02	Upgrade
EBIT	-14.66	-19.61	-14.64	-15.5	-15.18	Upgrade
EBIT Margin	-269.57%	-	-	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q